Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

The effects of collateral meridian therapy for knee osteoarthritis pain management: a pilot study
Horng H-C, Kuo C-P, Cherng C-H, Yeh C-C, Wang T-C, Liaw W-J, Ko S-C, Wong C-S
Journal of Manipulative and Physiological Therapeutics 2013 Jan;36(1):51-56
clinical trial
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVE: The purpose of this preliminary study was to examine whether collateral meridian (CM) therapy was feasible in treating knee osteoarthritis (OA) pain. METHODS: Twenty-eight patients with knee OA and knee pain were randomly allocated to 2 groups. The CM group patients received CM therapy, whereas the control patients received placebo treatment for knee pain relief. Patients in the CM group received 2 CM treatments weekly for 3 weeks. The outcome measures were pain intensity on a visual analog scale, and knee function was determined using the Western Ontario and McMaster Universities Osteoarthritis Index. RESULTS: In the CM group, the posttreatment visual analog scale and Western Ontario and McMaster Universities Osteoarthritis Index scores were lower than those of the control group; a significant reduction in pain intensity (p = 0.02, p = 0.01, respectively) and improvement in knee function (p = 0.04, p = 0.03, respectively) were shown in the CM group at the second and third week. CONCLUSION: Collateral meridian therapy may be feasible and effective for knee OA pain relief and knee function recovery. Therefore, additional randomized control trials are warranted.
Reprinted from the Journal of Manipulative and Physiological Therapeutics with copyright permission from the National University of Health Sciences.

Full text (sometimes free) may be available at these link(s):      help